Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-07-014214
Filing Date
2007-03-23
Accepted
2007-03-22 21:35:00
Documents
8
Period of Report
2006-12-31

Document Format Files

Seq Description Document Type Size
1 v068912_20f.htm 20-F 2710647
2 v068912_ex4-1.htm EX-4.1 1023
3 GRAPHIC v069141_ex4-1.jpg GRAPHIC 100303
4 v068912_ex10-32.htm EX-10.32 516591
5 v068912_ex10-33.htm EX-10.33 106182
6 v068912_ex31-1.htm EX-31.1 11805
7 v068912_ex31-2.htm EX-31.2 12232
8 v068912_ex32-1.htm EX-32.1 11562
  Complete submission text file 0001144204-07-014214.txt   3509706
Mailing Address KIRYAT WEIZMANN BUILDING 3 REHOVOT76100 ISRAEL L3 00000
Business Address KIRYAT WEIZMANN BUILDING 3 REHOVOT76100 ISRAEL L3
XTL BIOPHARMACEUTICALS LTD (Filer) CIK: 0001023549 (see all company filings)

EIN.: 000000000
Type: 20-F | Act: 34 | File No.: 000-51310 | Film No.: 07713301
SIC: 2834 Pharmaceutical Preparations